Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses

Sara Mariani, Cristiana Di Bello, Lisa Bonello, Fabrizio Tondat, Donatella Pacchioni, Luca Molinaro, Antonella Barreca, Luigia Macrì, Luigi Chiusa, Paola Francia Di Celle, Paola Cassoni, Anna Sapino

Research output: Contribution to journalArticle

Abstract

The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.

Original languageEnglish
Article numbere0121815
JournalPLoS One
Volume10
Issue number4
DOIs
Publication statusPublished - Apr 6 2015

Fingerprint

formalin
Formaldehyde
Tumors
neoplasms
Neoplasms
testing
mutation
sampling
somatic mutation
Mutation
Assays
DNA
assays
Molecular Diagnostic Techniques
melanoma
Cell Count
adenocarcinoma
Cells
alkanes
exons

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses. / Mariani, Sara; Di Bello, Cristiana; Bonello, Lisa; Tondat, Fabrizio; Pacchioni, Donatella; Molinaro, Luca; Barreca, Antonella; Macrì, Luigia; Chiusa, Luigi; Di Celle, Paola Francia; Cassoni, Paola; Sapino, Anna.

In: PLoS One, Vol. 10, No. 4, e0121815, 06.04.2015.

Research output: Contribution to journalArticle

Mariani, S, Di Bello, C, Bonello, L, Tondat, F, Pacchioni, D, Molinaro, L, Barreca, A, Macrì, L, Chiusa, L, Di Celle, PF, Cassoni, P & Sapino, A 2015, 'Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses', PLoS One, vol. 10, no. 4, e0121815. https://doi.org/10.1371/journal.pone.0121815
Mariani, Sara ; Di Bello, Cristiana ; Bonello, Lisa ; Tondat, Fabrizio ; Pacchioni, Donatella ; Molinaro, Luca ; Barreca, Antonella ; Macrì, Luigia ; Chiusa, Luigi ; Di Celle, Paola Francia ; Cassoni, Paola ; Sapino, Anna. / Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses. In: PLoS One. 2015 ; Vol. 10, No. 4.
@article{0cd54b050acf40eeaa8e56f5270054b8,
title = "Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses",
abstract = "The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.",
author = "Sara Mariani and {Di Bello}, Cristiana and Lisa Bonello and Fabrizio Tondat and Donatella Pacchioni and Luca Molinaro and Antonella Barreca and Luigia Macr{\`i} and Luigi Chiusa and {Di Celle}, {Paola Francia} and Paola Cassoni and Anna Sapino",
year = "2015",
month = "4",
day = "6",
doi = "10.1371/journal.pone.0121815",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses

AU - Mariani, Sara

AU - Di Bello, Cristiana

AU - Bonello, Lisa

AU - Tondat, Fabrizio

AU - Pacchioni, Donatella

AU - Molinaro, Luca

AU - Barreca, Antonella

AU - Macrì, Luigia

AU - Chiusa, Luigi

AU - Di Celle, Paola Francia

AU - Cassoni, Paola

AU - Sapino, Anna

PY - 2015/4/6

Y1 - 2015/4/6

N2 - The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.

AB - The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.

UR - http://www.scopus.com/inward/record.url?scp=84926676654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926676654&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0121815

DO - 10.1371/journal.pone.0121815

M3 - Article

AN - SCOPUS:84926676654

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e0121815

ER -